| Breakdown | TTM | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.66B | 5.32B | 3.64B | 2.29B | 3.67B | 2.56B |
| Gross Profit | 3.65B | 3.21B | 2.12B | 1.35B | 1.71B | 1.23B |
| EBITDA | 2.19B | 1.97B | 1.54B | 575.68M | 1.47B | 974.70M |
| Net Income | 2.49B | 2.18B | 1.41B | 450.91M | 1.30B | 829.14M |
Balance Sheet | ||||||
| Total Assets | 21.61B | 13.75B | 12.22B | 10.70B | 10.69B | 8.96B |
| Cash, Cash Equivalents and Short-Term Investments | 16.70B | 9.31B | 8.63B | 7.45B | 7.48B | 6.67B |
| Total Debt | 34.09M | 34.15M | 28.80M | 15.49M | 20.71M | 32.85M |
| Total Liabilities | 902.03M | 798.45M | 822.41M | 490.92M | 758.79M | 567.86M |
| Stockholders Equity | 20.78B | 12.93B | 11.40B | 10.19B | 9.91B | 8.39B |
Cash Flow | ||||||
| Free Cash Flow | 2.17B | 1.74B | 1.31B | 307.26M | 461.98M | 526.95M |
| Operating Cash Flow | 2.48B | 2.00B | 1.69B | 731.25M | 688.84M | 680.41M |
| Investing Cash Flow | -765.59M | 827.49M | -443.47M | -574.24M | 63.44M | 68.91M |
| Financing Cash Flow | 6.00B | -1.06B | -276.94M | -372.11M | -270.09M | -609.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$354.72B | 179.47 | 17.16% | ― | 40.74% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | HK$129.25B | 29.97 | 12.79% | ― | 10.28% | ― | |
55 Neutral | HK$849.24M | 26.93 | 4.98% | ― | -17.88% | -60.44% | |
41 Neutral | HK$8.22B | -5.23 | -81.95% | ― | ― | ― |